Streetbeat News

Stock Prices

ABT

Abbott Laboratories (NYSE:ABT) has received mixed analyst ratings over the past three months, with a majority being bullish. Analysts have set a 12-month price target range between $120 and $143, with an average of $127.2. The company's financial performance shows strong net margins and ROE, but revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

PEN

Penumbra (NYSE:PEN) has been analyzed by 13 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has decreased by 21.44% to $201.0. Analysts have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Penumbra's financials show revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

SLG

SL Green Realty (NYSE:SLG) has received mixed analyst ratings over the past three months, with a recent increase in the average 12-month price target to $55.92. Analysts have raised their price targets, reflecting a more positive outlook despite SL Green's recent financial challenges, including a decline in revenue and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

CRWD

CrowdStrike Holdings (NASDAQ:CRWD) has significantly outperformed the market over the past 5 years, with an average annual return of 26.38%. A $1000 investment in CRWD 5 years ago would now be worth $3,049.28, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

OCG

Oriental Culture Holding (NYSE:OCG) has seen a decrease in its short interest by 11.11%, with only 0.08% of its shares sold short. This is lower than the peer group average of 1.28%. The reduced short interest may indicate a more bullish sentiment among investors.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

TMO

Thermo Fisher Scientific (NYSE:TMO) has significantly outperformed the market over the past decade, with an annualized return of 17.54%. A $100 investment in TMO 10 years ago would now be worth $500.57, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

FUBO

FuboTV's short interest has decreased by 10.8%, with 15.2% of its shares sold short. This is higher than its peers' average of 4.62%. It would take 5.17 days to cover these positions. A decrease in short interest can indicate a more bullish sentiment.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

ALT

Four analysts have provided ratings for Altimmune (NASDAQ:ALT) over the past three months, with three bullish and one somewhat bullish. The average 12-month price target is $19.25, with a high of $25.00 and a low of $12.00. Altimmune faces challenges with a revenue decline of -16.67% and a net margin of -492800.0%, but maintains a low debt-to-equity ratio of 0.01.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

WFC

Wells Fargo's short interest has decreased by 9.09%, with 30.55 million shares sold short, representing 0.9% of its float. This is below the peer group average of 0.97%. The decrease in short interest may indicate a more bullish sentiment towards the stock.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 6:00 pm

BTCUSD

Jerome Powell is expected to signal a shift towards easing monetary policy at the Jackson Hole Economic Symposium, with a 25 basis point rate cut anticipated in September. This has kept U.S. financial markets buoyant, but Bitcoin remains below its all-time high despite positive crypto developments.

Portfolio Pulse from Murtuza Merchant

August 22, 2024 | 5:58 pm